ClinicalTrials.gov
History of Changes for Study: NCT01569295
A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Latest version (submitted March 2, 2020) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 March 30, 2012 None (earliest Version on record)
2 May 31, 2012 Recruitment Status, Study Status, Outcome Measures, Contacts/Locations and Oversight
3 June 18, 2012 Study Status
4 July 18, 2012 Study Status and Contacts/Locations
5 August 29, 2012 Study Status and Contacts/Locations
6 September 15, 2012 Study Status and Contacts/Locations
7 November 12, 2012 Contacts/Locations and Study Status
8 November 28, 2012 Contacts/Locations and Study Status
9 January 12, 2013 Arms and Interventions, Contacts/Locations, Study Description, Study Status, Study Identification and Conditions
10 March 11, 2013 Contacts/Locations and Study Status
11 March 18, 2013 Contacts/Locations and Study Status
12 June 24, 2013 Contacts/Locations and Study Status
13 August 20, 2013 Study Status and Contacts/Locations
14 September 20, 2013 Contacts/Locations and Study Status
15 December 23, 2013 Outcome Measures, Study Status, Study Description, Contacts/Locations, Arms and Interventions and Study Identification
16 February 6, 2014 Study Status and Contacts/Locations
17 March 7, 2014 Contacts/Locations and Study Status
18 April 14, 2014 Study Status and Contacts/Locations
19 May 22, 2014 Study Status and Contacts/Locations
20 July 2, 2014 Study Status and Contacts/Locations
21 July 24, 2014 Contacts/Locations and Study Status
22 September 5, 2014 Recruitment Status, Contacts/Locations, Arms and Interventions, Study Status, Outcome Measures and Conditions
23 October 21, 2014 Study Status and Contacts/Locations
24 May 1, 2015 Contacts/Locations and Study Status
25 December 4, 2015 Study Status
26 January 20, 2016 Study Status
27 May 24, 2016 Study Status, Study Design and Eligibility
28 June 9, 2017 Contacts/Locations, Study Status, Oversight, Eligibility and Study Identification
29 October 24, 2017 Study Status
Show
Results Submission Events
30 January 29, 2018 Study Status, Outcome Measures, More Information, References, Arms and Interventions, Adverse Events, Baseline Characteristics, Participant Flow, Contacts/Locations and Study Description
31 June 25, 2018 Study Status
32 October 9, 2018 Study Status
33 January 7, 2019 Study Status
34 May 6, 2019 Study Status
35 June 26, 2019 Recruitment Status, Study Status and IPDSharing
36 March 2, 2020 Outcome Measures, Adverse Events, Participant Flow, Baseline Characteristics, Study Status, More Information, IPDSharing, Document Section, Eligibility, Arms and Interventions, Conditions, Study Description and Study Identification
Comparison Format:
Scroll up to access the controls
Study NCT01569295
Submitted Date:  December 23, 2013 (v15)
Open or close this module Study Identification
Unique Protocol ID: GS-US-312-0115
Brief Title: A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia
Secondary IDs: 2011-006292-20 [EudraCT Number]
Open or close this module Study Status
Record Verification: December 2013
Overall Status: Recruiting
Study Start: June 2012
Primary Completion: December 2015 [Anticipated]
Study Completion: December 2016 [Anticipated]
First Submitted: March 27, 2012
First Submitted that
Met QC Criteria:		 March 30, 2012
First Posted: April 3, 2012 [Estimate]
Last Update Submitted that
Met QC Criteria:		 December 23, 2013
Last Update Posted: December 25, 2013 [Estimate]
Open or close this module Sponsor/Collaborators
Sponsor: Gilead Sciences
Responsible Party: Sponsor
Collaborators:
Open or close this module Oversight
U.S. FDA-regulated Drug:
U.S. FDA-regulated Device:
Data Monitoring: Yes
Open or close this module Study Description
Brief Summary: This Phase 3, randomized, double-blind, placebo-controlled study is to evaluate the effect of idelalisib on the onset, magnitude, and duration of tumor control. Eligible patients will be randomized with a 1:1 ratio into 1 of the 2 treatment arms to receive either idelalisib or placebo. All subjects will be administered bendamustine and rituximab.
Detailed Description:
Open or close this module Conditions
Conditions: Chronic Lymphocytic Leukemia
Keywords: CLL
CAL 101
CAL-101
GS 1101
GS-1101
PI3K
Rituxan
Rituximab
Bendamustine
Leukemia
idelalisib
Open or close this module Study Design
Study Type: Interventional
Primary Purpose: Treatment
Study Phase: Phase 3
Interventional Study Model: Parallel Assignment
Number of Arms: 2
Masking: Triple (Participant, Care Provider, Investigator)
Allocation: Randomized
Enrollment: 390 [Anticipated]
Open or close this module Arms and Interventions
Arms Assigned Interventions
Active Comparator: Idelalisib + bendamustine/rituximab Drug: Idelalisib
Idelalisib 150 mg administered orally twice daily
Other Names:
  • GS-1101
  • CAL 101
  • CAL-101
Drug: Rituximab
Rituximab 375 mg/m^2 on Day 1, then 500 mg/m^2 administered intravenously thereafter
Other Names:
  • Rituxan, MabThera
Drug: Bendamustine
Bendamustine 70 mg/mg^2/day on 2 consecutive days every 28 days administered intravenously
Other Names:
  • Ribomustin, Treanda, SDX-105
Placebo Comparator: Placebo + bendamustine/rituximab Drug: Rituximab
Rituximab 375 mg/m^2 on Day 1, then 500 mg/m^2 administered intravenously thereafter
Other Names:
  • Rituxan, MabThera
Drug: Bendamustine
Bendamustine 70 mg/mg^2/day on 2 consecutive days every 28 days administered intravenously
Other Names:
  • Ribomustin, Treanda, SDX-105
Drug: Placebo
Placebo to match idelalisib administered orally twice daily
Open or close this module Outcome Measures
Primary Outcome Measures:
1. Progression-Free Survival
[ Time Frame: Baseline to Month 30 ]

Progression-free survival (PFS) is defined as the interval from randomization to the earlier of the first documentation of definitive disease progression or death from any cause.
Secondary Outcome Measures:
1. Overall Response Rate
[ Time Frame: Baseline to Month 30 ]

Overall response rate (ORR) is defined as the proportion of participants who achieve a complete response or partial response.
2. Lymph Node Response Rate
[ Time Frame: Baseline to Month 30 ]

Lymph node response rate is defined as the proportion of participants who achieve a ≥ 50% decrease from baseline in the sum of the products of the greatest perpendicular diameters (SPD) of index lymph nodes.
3. Overall Survival
[ Time Frame: Baseline to Month 30 ]

Overall survival (OS) is defined as the interval from randomization to death from any cause.
4. Complete Response Rate
[ Time Frame: Baseline to Month 30 ]

Complete response (CR) rate is defined as the proportion of participants who achieve a CR.
Open or close this module Eligibility
Minimum Age: 18 Years
Maximum Age:
Sex: All
Gender Based:
Accepts Healthy Volunteers: No
Criteria:

Inclusion:

  • Previously treated recurrent CLL
  • Measurable lymphadenopathy
  • Requires therapy for CLL
  • Has experienced CLL progression <36 months since the completion of the last prior therapy

Exclusion:

  • Recent history of a major non-CLL malignancy
  • Evidence of an ongoing infection
  • CLL refractory to bendamustine
  • Concurrent participation in another therapeutic clinical trial
Open or close this module Contacts/Locations
Central Contact Person: Shelley Evans
Telephone: 206-256-4974
Email: Shelley.Evans@gilead.com
Study Officials: Thomas Jahn, MD
Study Director
Gilead Sciences
Locations: United States, Alabama
Clearview Cancer Institute
[Recruiting]
Huntsville, Alabama, United States, 35805
Contact:Contact: Kathy Cutter 256-705-4248
United States, California
Providence Holy Cross Medical Center
[Recruiting]
Mission Hills, California, United States, 91345
Contact:Contact: Cathy Madrid 818-365-3099 cathy.madrid@providence.org
Stanford Cancer Center
[Recruiting]
Palo Alto, California, United States, 94304
Contact:Contact: Zayna Shaheen 650-723-5957 zshaheen@stanford.edu
UCLA Medical Center
[Recruiting]
Santa Monica, California, United States, 90404
Contact:Contact: Ashlee Gonzales 310-829-5471
United States, Colorado
Rocky Mountain Cancer Center
[Recruiting]
Denver, Colorado, United States, 80218
Contact:Contact: Katherine Schleich 303-388-4876 katherine.schleich@usoncology.com
United States, Florida
University of Florida
[Recruiting]
Gainsville, Florida, United States, 32610
Contact:Contact: Cathy Spears 352-265-0680 Ext. 87658 cdspears@ufl.edu
United States, Massachusetts
Dana Farber Cancer Institute
[Recruiting]
Boston, Massachusetts, United States, 02215
Contact:Contact: Elizabeth Coughlin ElizabethO_Coughlin@DFCI.HARVARD.EDU
United States, Minnesota
Minnesota Oncology Hematology, PA
[Recruiting]
Minneapolis, Minnesota, United States, 55404
Contact:Contact: Lynn Anderson 612-884-6300 lynn.anderson@usoncology.com
United States, Nebraska
University of Nebraska Medical Center
[Recruiting]
Omaha, Nebraska, United States, 68198
Contact:Contact: Susan Blumel, 402-559-9183 sblumel@unmc.edu
United States, New Jersey
Hackensack University Medical Center
[Recruiting]
Hackensack, New Jersey, United States, 07601
Contact:Contact: Marisa Valentinetti 201-336-8073 mvalentinetti@hackensackumc.org
Hematology Oncology Associates of Northern New Jersey
[Recruiting]
Morristown, New Jersey, United States, 07962
Contact:Contact: Michelle Mackenzie mmackenzie@hoannj.com
United States, New York
Long Island Jewish Medical Center
[Recruiting]
New Hyde Park, New York, United States, 11042
Contact:Contact: Kaur Manmeen 516-470-4050 Mkaur5@nshs.edu
Weill Cornell Medical College
[Recruiting]
New York, New York, United States, 10021
Contact:Contact: James McConnell 212-746-1493 jam2064@med.cornell.edu
Columbia University Medical Center
[Recruiting]
New York, New York, United States, 10032
Contact:Contact: Hanna Weissbrot 212-304-5558 hw2432@mail.cumc.columbia.edu
Memorial Sloan Kettering Cancer Center
[Recruiting]
New York, New York, United States, 10065
Contact:Contact: Talal Khawaja 646-497-9133
Contact:Contact: Lupe Zuniga-Estrada (646) 497-9152
United States, Oregon
Willamette Valley Cancer Center
[Recruiting]
Eugene, Oregon, United States, 97401
Contact:Contact: Wade Carson 541-683-5001 wade.carson@usoncology.com
Northwest Cancer Specialists, PC
[Recruiting]
Portland, Oregon, United States, 97225
Contact:Contact: Tamyra Batsch 503-291-6233 tamyra.batsch@usoncology.com
United States, South Carolina
Charleston Hematology Oncology
[Recruiting]
Charleston, South Carolina, United States, 29414
Contact:Contact: Deborah McNeal 843-577-6957 d.mcneal@choasc.com
Greenville Health System
[Recruiting]
Greenville, South Carolina, United States, 29605
Contact:Contact: William J Edenfield, MD 864-679-3926 jedenfield@ghs.org
United States, Texas
Texas Oncology
[Recruiting]
Austin, Texas, United States, 78731
Contact:Contact: Lauren Hendrix 512-427-9400 lauren.hendrix@usoncology.com
Texas Oncology PA
[Recruiting]
Dallas, Texas, United States, 78246
Contact:Contact: Rita Lopez 214-370-1000 rita.lopez2@usoncology.com
Texas Oncology, P.A.
[Recruiting]
Fort Worth, Texas, United States, 76104
Contact:Contact: Nori Sullivan Nori.Sullivan@usoncology.com
M.D. Anderson Cancer Center
[Recruiting]
Houston, Texas, United States, 77030
Contact:Contact: Susan O'Brien, MD sobrien@mdanderson.org
Cancer Care Network of South Texas
[Recruiting]
San Antonia, Texas, United States, 78217
Contact:Contact: Elizabeth Guthrie elizabeth.guthrie@usoncology.com
Cancer Care Centers of South Texas
[Recruiting]
San Antonio, Texas, United States, 78229
Contact:Contact: Patricia Manea 210-595-5300 patricia.manea@usoncology.com
United States, Washington
Seattle Cancer Care Alliance
[Recruiting]
Seattle, Washington, United States, 98109
Contact:Contact: Dai Nguyen 206-667-7809 dnguyen@fhcrc.org
Cancer Care Northwest, US Oncology
[Recruiting]
Spokane, Washington, United States, 99202
Contact:Contact: Rachel Garman 509-228-1000 rachel.garman@ccnw.net
Yakima Valley Memorial Hospital
[Recruiting]
Yakima, Washington, United States, 98902
Contact:Contact: Beth Parker 509-574-3493 bethparker@yvmh.org
United States, Wisconsin
Medical College of Wisconsin
[Recruiting]
Milwaukee, Wisconsin, United States, 53226
Contact:Contact: Hemavathy Sunderraj hsunderraj@mcw.edu
Belgium
Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg
[Recruiting]
Antwerpen, Belgium, 2060
Contact:Contact: Karen Cox +32 3 217 74 48 studiebureau.hematologie@zna.be
Contact:Contact: Caroline De Man +32 3 217 74 48 Caroline.deman@zna.be
UZ Antwerpen
[Recruiting]
Edegem, Belgium, 2650
Contact:Contact: Pascale De Graef +32 3 821 32 32 Pascale.DeGraef@uza.be
UZ Gent
[Recruiting]
Gent, Belgium, 9000
Contact:Contact: Charlotte Dekeyzer +32 9 332 87 70 charlotte.dekeyzer@uzgent.be
UZ Leuven
[Recruiting]
Leuven, Belgium, 3000
Contact:Contact: Saskia Cremers +32 16 34 68 90 saskia.cremers@uzleuven.be
Contact:Contact: Hannelore Van Eeckhaute +32 16 34 19 69 hannelore.vaneeckhaute@uzleuven.be
France
Hôpital Henri Mondor
[Recruiting]
Creteil, France, 94010
Contact:Contact: Feriel Bouabbas +33 1 49 81 41 82 feriel.bouabbas@hmn.aphp.fr
Centre Jean Bernard - Clinique Victor Hugo
[Recruiting]
Le Mans cedex, France, 72015
Contact:Contact: Hélène Dervaux +33 2 43 29 79 08 hdervaux_sorecoh@yahoo.fr
CHRU Lille-Hôpital Claude Huriez
[Recruiting]
Lille, France, 59045
Contact:Contact: Franck Morschhauser +33 3 20 44 60 68 fmorschhauser@gmail.com
Centre Hospitalier de Mulhouse
[Recruiting]
Mulhouse, France, 68100
Contact:Contact: Alice Techer +33 03 89 64 77 69 alice.techer@ch-mulhouse.fr
CHU Hôtel-Dieu-Service Hématologie
[Recruiting]
Nantes, France, 44 093
Contact:Contact: Anna Testu +33 2 40 08 32 89 anna.testu@chu-nantes.fr
Contact:Contact: Nathalie Trehet +33 2-40-08-30-13 Nathalie.TREHET@chu-nantes.fr
Centre Hospitalier Lyon Sud
[Recruiting]
Pierre Bénite, France, Pierre Bénite
Contact:Contact: Samuel Moulle +33 4 78 86 12 03 samuel.moulle@chu-lyon.fr
Hopital Purpan
[Recruiting]
Toulouse, France, 31059
Contact:Contact: Nogaro Jean-Claude +33 5 61 77 76 66 nogaro.jc@chu-toulouse.fr
Hôpitaux de Brabois
[Recruiting]
Vandoeuvre-lés-Nancy, France, 54511
Contact:Contact: David Schwartz +33 3 83 15 37 05 d.schwartz@chu-nancy.fr
Italy
Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi
[Recruiting]
Bologna, Italy, 40138
Contact:Contact: Lisa Argnani +39 051 636 3227 lisa.argnani@unibo.it
Contact:Contact: Marta Tschon +39 051 636 3227 marta.tschon2@unibo.it
Spedali Civili di Brescia
[Recruiting]
Brescia, Italy, 25123
Contact:Contact: Marta Petullà +39 030 3996269 marta-petulla@hotmail.it
Ospedale Oncologico Regionale A. Businco
[Recruiting]
Cagliari, Italy, 9121
Contact:Contact: Emanuele Angelucci, MD +39 070 6095312 emnang@tin.it
Ospedale San Raffaele S.r.l.
[Recruiting]
Milano, Italy, 20132
Contact:Contact: Lydia Scarfò +39 347 6866923 scarfo.lydia@hsr.it
Azienda Ospedaliera Niguarda Cà Granda
[Recruiting]
Milano, Italy, 20162
Contact:Contact: Chiara Colombo +39 02 64444941 chiara.colombo@ospedaleniguarda.it
Azienda Ospedaliera Città della Salute e della Scienza di Torino
[Recruiting]
Torino, Italy, 10126
Contact:Contact: Marta Santoro +39 011 6336107-4565 marta.santoro91@yahoo.it
Poland
Szpital Specjalistyczny w Brzozowie
[Recruiting]
Brzozow, Poland, 36-200
Contact:Contact: Jacek Krzanowski +48 13 430 97 28 jacek.krzanowski@gmail.com
Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
[Recruiting]
Lodz, Poland, 93-510
Contact:Contact: Barbara Cebula-Obrzut +48 503 90 78 51 barbara_cebula@wp.pl
Contact:Contact: Pawel Robak +48 42 689 5191
Samodzielny Publiczny Szpital Kliniczny Nr 1
[Recruiting]
Lublin, Poland, 20-081
Contact:Contact: Malgorzata Wach mijwach@poczta.onet.pl mijwach@poczta.onet.pl
Centralny Szpital Kliniczny MSW w Warszawie
[Recruiting]
Warszawa, Poland, 02-507
Contact:Contact: Joanna Omyla-Staszewska, MD +48 22 508 19 80 joannaomyla@gmail.com
Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie
[Recruiting]
Warszawa, Poland, 02-781
Contact:Contact: Magdalena Barbasiewicz +48 22 5462426
Contact:Contact: Gabriela Zaleskiewicz-Pietrzak +48 22 5462426 gabi@coi.waw.pl
Russian Federation
Russian Oncology Research Center (N.N. Blokhin)
[Recruiting]
Moscow, Russian Federation, 115478
Contact:Contact: Olga Yurievna Baranova (925) 837-2708 baranova-crc@mail.ru
Nizhegorodskaya Regional Clinical Hospital n.a. N.A. Semashko
[Recruiting]
Nizhniy Novgorod, Russian Federation, 603126
Contact:Contact: Olga S Samoilova, MD +7(8) 312 38 93 Ext. 03
Ryazan Regional Clinical Hospital
[Recruiting]
Ryazan, Russian Federation, 390039
Contact:Contact: Alexander Pristupa, PHD, MD alpristupa@mail.ru
Samara Regional Clinical Hospital named after M.I. Kalinin
[Recruiting]
Samara, Russian Federation, 443095
Contact:Contact: Viktor Rossiev, PHD rossiev_v@mail.ru
Saratov State Medical University
[Recruiting]
Saratov, Russian Federation, 410028
Contact:Contact: Varvara Sergeevna Bogova (927) 123-5077 bogova82@mail.ru
Research Institute of Hematology and Blood Transfusion
[Recruiting]
St. Petersburg, Russian Federation, 193024
Contact:Contact: Kudrat Abdulkadyrov, MD haematology@atlant.ru
Spain
Hospital Universitario de La Princesa
[Recruiting]
Madrid, Spain, 28033
Contact:Contact: Pilar Souviron 34915202441 Pilar.Souviron@tfscro.com
Hospital J.M. Morales Meseguer
[Recruiting]
Murcia, Spain, 30008
Contact:Contact: Jose Galvez 34968360969 josegalvez100@gmail.com
Spain, Cataluña
Hospital Universitario Germans Trias i Pujol
[Recruiting]
Badalona, Cataluña, Spain, 08916
Contact:Contact: Christelle Ferra i Col, MD 34934978987 cferra@iconcologia.net
Hospital Clinic de Barcelona
[Recruiting]
Barcelona, Cataluña, Spain, 8036
Contact:Contact: Antonio De La Riva 34932279214 DELARIVA@clinic.ub.es
Hospital de la Santa Creu i Sant Pau
[Recruiting]
Barcelona, Cataluña, Spain, 8041
Contact:Contact: Silvia Borrell 34935537142 SBorrell@santpau.cat
Spain, Madrid, Communidad de
Hospital 12 de Octubre
[Recruiting]
Madrid, Madrid, Communidad de, Spain, 28041
Contact:Contact: Javier De La Serna 34913908413 drjdelaserna@gmail.com
Hospital Universitario Puerta de Hierro
[Recruiting]
Majadahonda, Madrid, Communidad de, Spain, 28222
Contact:Contact: Ana Garranzo, Ana 34911917763
United Kingdom
Birmingham Heartlands Hospital
[Recruiting]
Birmingham, United Kingdom, B9 5SS
Contact:Contact: James Whitehouse +44(0)121 424 1075 james.whitehouse@heartofengland.nhs.uk
Kent and Canterbury Hospital
[Recruiting]
Canterbury, United Kingdom, CT1 3NG
Contact:Contact: Lavinia Parsons +44(0)1227 864129 lavinia.parsons@nhs.net
University Hospital of Wales
[Recruiting]
Cardiff, United Kingdom, CF14 4XW
Contact:Contact: Sophie Norton +44(0)2920 744147 Sophie.Norton@wales.nhs.uk
Dorset County Hospital
[Recruiting]
Dorchester, United Kingdom, DT1 2JY
Contact:Contact: Sally Love +44(0)1305 255261 Sally.love@dchft.nhs.uk
Northwick Park Hospital
[Recruiting]
Harrow, United Kingdom, HA1 3UJ
Contact:Contact: Shelley Harvey +44(0)208 869 5088 shelleyharvey1@nhs.net
St James's University Hospital
[Recruiting]
Leeds, United Kingdom, LS9 7TF
Contact:Contact: Catherine Norton +44(0)113 206 8577 catherine.norton@leedsth.nhs.uk
Royal Liverpool University Hospital
[Recruiting]
Liverpool, United Kingdom, L7 8XP
Contact:Contact: Tracey Wellman +44(0)151 706 4889 Tracey.Wellman@rlbuht.nhs.uk
St Bartholomews Hospital
[Recruiting]
London, United Kingdom, EC1A 7BE
Contact:Contact: Tobi Sogbanmu +44(0)2034656758 tobi.sogbanmu@bartshealth.nhs.uk
University College London
[Recruiting]
London, United Kingdom, NW1 2PG
Contact:Contact: Joanna Calvert (448) 451-5550 Ext. 0078260 joanna.calvert@uclh.nhs.uk
Contact:Contact: Sharon Edleston +44(0)845 1555000 Ext. 4184 Sharon.edleston@uclh.nhs.uk
King's College Hospital
[Recruiting]
London, United Kingdom, SE5 9RS
Contact:Contact: Jen Lewis +44(0)20 3299 5061 jen.lewis@nhs.net
Contact:Contact: Jonathon Samuel +44(0)203 299 5769 jonathon.samuel@nhs.net
Hammersmith Hospital
[Recruiting]
London, United Kingdom, W12 0NN
Contact:Contact: Christos Paliompeis +44(0)208 383 4715 c.paliompeis@imperial.ac.uk
Sarah Cannon Research Institute UK
[Recruiting]
London, United Kingdom, W1G 6AD
Contact:Contact: Joana Hauser +44(0)203 219 5253 Joana.Hauser@HCAHealthcare.co.uk
Contact:Contact: Mary-Jane Lauigan +44(0)203 219 5218 MaryJane.Lauigan@HCAHealthcare.co.uk
Christie Hospital
[Recruiting]
Manchester, United Kingdom, M20 4BX
Contact:Contact: Stephanie Manning +44(0)161 918 7248 Stephanie.Manning@christie.nhs.uk
Nottingham University Hospitals NHS Trust
[Recruiting]
Nottingham, United Kingdom, NG5 1PB
Contact:Contact: Richard Stanley +44(0)115 9691169 Ext. 55702 richard.stanley@nuh.nhs.uk
Churchill Hospital
[Recruiting]
Oxford, United Kingdom, OX3 7LE
Contact:Contact: Julia Laurence +44(0)1865 572048 Julia.Laurence@ouh.nhs.uk
Salisbury District Hospital
[Recruiting]
Salisbury, United Kingdom, SP2 8BJ
Contact:Contact: Claire Smith +44(0)1722 336262 x2103 claire.smith@salisbury.nhs.uk
Great Western Hospital
[Recruiting]
Swindon, United Kingdom, SN3 6BB
Contact:Contact: Tim Owen +44(0)1793 604506 Tim.Owen@gwh.nhs.uk
Torbay District General Hospital
[Recruiting]
Torquay, United Kingdom, TQ2 7AA
Contact:Contact: Lyn Micklewright +44(0)1803 656623 sdhct.cancertrialstorbay@nhs.net
Contact:Contact: Lorraine Thornton +44(0)1803 656624 lorraine.thornton@nhs.net
Royal Cornwall Hospital
[Recruiting]
Truro, United Kingdom, TR1 3LJ
Contact:Contact: Sophie Mepham +44(0)1872 252527 sophie.mepham@rcht.cornwall.nhs.uk
Contact:Contact: Bianca Mills +44(0)1872 25 2527 Bianca.Mills@rcht.cornwall.nhs.uk
New Cross Hospital
[Recruiting]
Wolverhampton, United Kingdom, WV10 0QP
Contact:Contact: Claire Beardsmore +44(0)1902 694430 claire.beardsmore@nhs.net
Yeovil District Hospital
[Recruiting]
Yeovil, United Kingdom, BA21 4AT
Contact:Contact: Nigel Beer +44(0)1935 384798 Nigel.Beer@YDH.NHS.UK
Open or close this module IPDSharing
Plan to Share IPD:
Open or close this module References
Links:
Available IPD/Information:
Scroll up to access the controls Scroll to the Study top
U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services